Probity Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.31M | Sell |
9,437
-417
| -4% | -$97.1K | 0.37% | 58 |
|
|
2025
Q4 | $2.04M | Sell |
9,854
-229
| -2% | -$45.3K | 0.33% | 60 |
|
|
2025
Q3 | $1.87M | Sell |
10,083
-70
| -0.7% | -$12K | 0.3% | 63 |
|
|
2025
Q2 | $1.55M | Buy |
10,153
+9
| +0.1% | +$1.38K | 0.27% | 64 |
|
|
2025
Q1 | $1.68M | Sell |
10,144
-297
| -3% | -$46.5K | 0.32% | 56 |
|
|
2024
Q4 | $1.51M | Sell |
10,441
-266
| -2% | -$41.2K | 0.29% | 60 |
|
|
2024
Q3 | $1.74M | Buy |
10,707
+179
| +2% | +$28.5K | 0.33% | 61 |
|
|
2024
Q2 | $1.54M | Buy |
10,528
+15
| +0.1% | +$2.23K | 0.32% | 63 |
|
|
2024
Q1 | $1.66M | Buy |
10,513
+116
| +1% | +$18.5K | 0.34% | 65 |
|
|
2023
Q4 | $1.63M | Sell |
10,397
-345
| -3% | -$52.9K | 0.36% | 57 |
|
|
2023
Q3 | $1.67M | Buy |
10,742
+70
| +0.7% | +$11.6K | 0.39% | 44 |
|
|
2023
Q2 | $1.77M | Buy |
+10,672
| New | +$1.72M | 0.39% | 43 |
|
|
2022
Q4 | $1.98M | Sell |
11,235
-222
| -2% | -$38.3K | 0.45% | 39 |
|
|
2022
Q3 | $1.87M | Sell |
11,457
-739
| -6% | -$125K | 0.46% | 37 |
|
|
2022
Q2 | $2.17M | Sell |
12,196
-466
| -4% | -$83K | 0.5% | 34 |
|
|
2022
Q1 | $2.24M | Sell |
12,662
-556
| -4% | -$94.6K | 0.46% | 38 |
|
|
2021
Q4 | $2.26M | Sell |
13,218
-209
| -2% | -$34.2K | 0.45% | 40 |
|
|
2021
Q3 | $2.17M | Buy |
13,427
+312
| +2% | +$53.2K | 0.45% | 41 |
|
|
2021
Q2 | $2.16M | Buy |
13,115
+178
| +1% | +$29.5K | 0.46% | 42 |
|
|
2021
Q1 | $2.13M | Buy |
+12,937
| New | +$2.09M | 0.47% | 42 |
|
|
2020
Q3 | $1.97M | Sell |
13,247
-100
| -0.7% | -$14.8K | 0.56% | 37 |
|
|
2020
Q2 | $1.88M | Buy |
13,347
+188
| +1% | +$27.4K | 0.58% | 36 |
|
|
2020
Q1 | $1.73M | Sell |
13,159
-58
| -0.4% | -$8.23K | 0.63% | 31 |
|
|
2019
Q4 | $1.93M | Sell |
13,217
-112
| -0.8% | -$15.2K | 0.58% | 38 |
|
|
2019
Q3 | $1.73M | Buy |
13,329
+27
| +0.2% | +$3.56K | 0.56% | 39 |
|
|
2019
Q2 | $1.85M | Sell |
13,302
-342
| -3% | -$47.3K | 0.62% | 37 |
|
|
2019
Q1 | $1.91M | Buy |
13,644
+298
| +2% | +$39.9K | 0.66% | 37 |
|
|
2018
Q4 | $1.72M | Sell |
13,346
-256
| -2% | -$35.7K | 0.64% | 39 |
|
|
2018
Q3 | $1.88M | Sell |
13,602
-95
| -0.7% | -$12.6K | 0.61% | 38 |
|
|
2018
Q2 | $1.66M | Buy |
13,697
+215
| +2% | +$26.8K | 0.58% | 41 |
|
|
2018
Q1 | $1.73M | Sell |
13,482
-62
| -0.5% | -$8.38K | 0.6% | 38 |
|
|
2017
Q4 | $1.89M | Sell |
13,544
-347
| -2% | -$48.3K | 0.66% | 34 |
|
|
2017
Q3 | $1.81M | Buy |
13,891
+384
| +3% | +$50.9K | 0.67% | 29 |
|
|
2017
Q2 | $1.79M | Sell |
13,507
-251
| -2% | -$32K | 0.67% | 31 |
|
|
2017
Q1 | $1.71M | Buy |
13,758
+28
| +0.2% | +$3.35K | 0.66% | 32 |
|
|
2016
Q4 | $1.58M | Buy |
13,730
+703
| +5% | +$81.2K | 0.67% | 34 |
|
|
2016
Q3 | $1.54M | Sell |
13,027
-184
| -1% | -$22.3K | 0.66% | 31 |
|
|
2016
Q2 | $1.6M | Buy |
+13,211
| New | +$1.5M | 0.72% | 29 |
|
Other funds holding JNJ
VCM
VPM
Probity Advisors's JNJ Position: Q1 2026 in Review
Probity Advisors reduced its Johnson & Johnson (JNJ) stake by 4.2% in Q1 2026, selling an estimated $97.1K and leaving 9,437 shares worth $2.31M. The position accounts for 0.37% of the portfolio, ranked #58.
Probity Advisors first reported a position in JNJ in Q2 2016 and has held it in 38 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Probity Advisors held 9,437 shares of Johnson & Johnson worth $2.31M as of Q1 2026.
- Probity Advisors sold 417 Johnson & Johnson shares in Q1 2026, an estimated $97.1K.
- Johnson & Johnson made up 0.37% of Probity Advisors's portfolio in Q1 2026, its #58 holding.
- Probity Advisors first reported a position in Johnson & Johnson in Q2 2016 and has held it in 38 quarters since.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Probity Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.